Pearl’s Second Opinion AI Software Receives the US FDA’s Clearance to Identify Dental Diseases
Shots:
- The US FDA has cleared Al-powered real-time pathology detection solution ‘Second Opinion’ to identify dental conditions in patient x-rays including tooth decay, calculus & root abscesses that allowing dentists to better screen for oral pathologies
- In 4 clinical studies, Second Opinion outperformed the US FDA's demanding efficacy standards that feature a radiographic dataset of ~2,000 images & 86 expert dentists/dental radiologists. The tests showed the benefits for readers using Second Opinion & accurately spotted 36% more lesions than those without AI assistance
- Second Opinion is 1st AI-driven computer-aided clinical radiology solution for dentists throughout North America, EU Australia & other countries
Ref: Businesswire | Image: Businesswire
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
